Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2005. Start Trial.
Date Value
October 07, 2026 5.72
October 06, 2026 5.72
October 05, 2026 5.72
October 02, 2026 5.72
October 01, 2026 5.72
September 30, 2026 5.72
September 29, 2026 5.72
September 28, 2026 5.72
September 25, 2026 5.72
September 24, 2026 5.72
September 23, 2026 5.72
September 22, 2026 5.72
September 21, 2026 5.72
September 18, 2026 5.72
September 17, 2026 5.72
September 16, 2026 5.72
September 15, 2026 5.72
September 14, 2026 5.72
September 11, 2026 5.72
September 10, 2026 5.72
September 09, 2026 5.72
September 08, 2026 5.72
September 04, 2026 5.72
September 03, 2026 5.72
September 02, 2026 5.72
Date Value
September 01, 2026 5.72
August 31, 2026 5.72
August 28, 2026 5.887
August 27, 2026 5.887
August 26, 2026 5.296
August 25, 2026 5.296
August 24, 2026 5.296
August 21, 2026 5.296
August 20, 2026 5.296
August 19, 2026 5.296
August 18, 2026 5.296
August 17, 2026 5.296
August 14, 2026 5.296
August 13, 2026 5.296
August 12, 2026 5.296
August 11, 2026 5.296
August 10, 2026 5.296
August 07, 2026 5.296
August 06, 2026 5.296
August 05, 2026 5.296
August 04, 2026 5.205
August 03, 2026 5.205
July 31, 2026 5.205
July 30, 2026 5.205
July 29, 2026 5.205

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Oryzon Genomics SA 2.015
Grifols SA 0.7943
ACADIA Pharmaceuticals, Inc. 2.578
Alkermes Plc 3.716
Alnylam Pharmaceuticals, Inc. 22.17

Price to Book Value Related Metrics